213 related articles for article (PubMed ID: 27056631)
1. A Dual-Ligand Liposomal System Composed of a Cell-Penetrating Peptide and a Mitochondrial RNA Aptamer Synergistically Facilitates Cellular Uptake and Mitochondrial Targeting.
Yamada Y; Furukawa R; Harashima H
J Pharm Sci; 2016 May; 105(5):1705-1713. PubMed ID: 27056631
[TBL] [Abstract][Full Text] [Related]
2. A photo-responsive peptide- and asparagine-glycine-arginine (NGR) peptide-mediated liposomal delivery system.
Xie X; Yang Y; Yang Y; Zhang H; Li Y; Mei X
Drug Deliv; 2016 Sep; 23(7):2445-2456. PubMed ID: 25693640
[TBL] [Abstract][Full Text] [Related]
3. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.
Kibria G; Hatakeyama H; Harashima H
Int J Pharm; 2011 Jun; 412(1-2):106-14. PubMed ID: 21414394
[TBL] [Abstract][Full Text] [Related]
4. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.
Ara MN; Matsuda T; Hyodo M; Sakurai Y; Hatakeyama H; Ohga N; Hida K; Harashima H
Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764
[TBL] [Abstract][Full Text] [Related]
5. Design of Multifunctional Liposomal Nanocarriers for Folate Receptor-Specific Intracellular Drug Delivery.
Kang MH; Yoo HJ; Kwon YH; Yoon HY; Lee SG; Kim SR; Yeom DW; Kang MJ; Choi YW
Mol Pharm; 2015 Dec; 12(12):4200-13. PubMed ID: 26544061
[TBL] [Abstract][Full Text] [Related]
6. Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.
Kang MJ; Park SH; Kang MH; Park MJ; Choi YW
Int J Nanomedicine; 2013; 8():1155-65. PubMed ID: 23515421
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Yamada Y; Hashida M; Harashima H
Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
[TBL] [Abstract][Full Text] [Related]
8. Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA coding mitochondrial proteins by cell-penetrating peptides.
Cerrato CP; Kivijärvi T; Tozzi R; Lehto T; Gestin M; Langel Ü
J Mater Chem B; 2020 Dec; 8(47):10825-10836. PubMed ID: 33174901
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial targeting functional peptides as potential devices for the mitochondrial delivery of a DF-MITO-Porter.
Kawamura E; Yamada Y; Harashima H
Mitochondrion; 2013 Nov; 13(6):610-4. PubMed ID: 24012978
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
Yuan M; Qiu Y; Zhang L; Gao H; He Q
Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
[TBL] [Abstract][Full Text] [Related]
11. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
12. Improving the efficacy of liposome-mediated vascular gene therapy via lipid surface modifications.
Fisher RK; Mattern-Schain SI; Best MD; Kirkpatrick SS; Freeman MB; Grandas OH; Mountain DJH
J Surg Res; 2017 Nov; 219():136-144. PubMed ID: 29078873
[TBL] [Abstract][Full Text] [Related]
13. Enhancement in selective mitochondrial association by direct modification of a mitochondrial targeting signal peptide on a liposomal based nanocarrier.
Yamada Y; Harashima H
Mitochondrion; 2013 Sep; 13(5):526-32. PubMed ID: 23000575
[TBL] [Abstract][Full Text] [Related]
14. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery.
Yang Y; Yang Y; Xie X; Wang Z; Gong W; Zhang H; Li Y; Yu F; Li Z; Mei X
Biomaterials; 2015 Apr; 48():84-96. PubMed ID: 25701034
[TBL] [Abstract][Full Text] [Related]
15. Bifunctional peptide hybrids targeting the matrix of mitochondria.
Klimpel A; Neundorf I
J Control Release; 2018 Dec; 291():147-156. PubMed ID: 30367921
[TBL] [Abstract][Full Text] [Related]
16. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
[TBL] [Abstract][Full Text] [Related]
17. Intracellular observation of nanocarriers modified with a mitochondrial targeting signal peptide.
Kawamura E; Yamada Y; Yasuzaki Y; Hyodo M; Harashima H
J Biosci Bioeng; 2013 Nov; 116(5):634-7. PubMed ID: 23735326
[TBL] [Abstract][Full Text] [Related]
18. Validation of a Strategy for Cancer Therapy: Delivering Aminoglycoside Drugs to Mitochondria in HeLa Cells.
Abe J; Yamada Y; Harashima H
J Pharm Sci; 2016 Feb; 105(2):734-740. PubMed ID: 26523487
[TBL] [Abstract][Full Text] [Related]
19. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue.
Hossen MN; Kajimoto K; Akita H; Hyodo M; Ishitsuka T; Harashima H
J Control Release; 2010 Oct; 147(2):261-8. PubMed ID: 20647023
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Use of a Multi-DNA Aptamer-Based Payload/Targeting System To Study Dopamine Dysregulation in the Central Nervous System.
McConnell EM; Ventura K; Dwyer Z; Hunt V; Koudrina A; Holahan MR; DeRosa MC
ACS Chem Neurosci; 2019 Jan; 10(1):371-383. PubMed ID: 30160936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
